Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Reliable In Silico Ranking of Engineered Therapeutic TCR Binding Affinities with MMPB/GBSA
Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Bath, Doctoral Training Ctr Sustainable Chem Technol, Bath BA2 7AY, Avon, England.ORCID iD: 0000-0003-4709-5353
Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.;Univ Bath, Ctr Therapeut Innovat, Bath BA2 7AY, Avon, England..
Immunocore Ltd, Abingdon OX14 4RY, Oxon, England.;Cardiff Univ, Div Infect & Immun, Cardiff CF14 4XN, Wales..
Univ Bristol, Sch Biochem, Bristol BS8 1TD, Avon, England..ORCID iD: 0000-0002-8060-3359
2022 (English)In: Journal of Chemical Information and Modeling, ISSN 1549-9596, E-ISSN 1549-960X, Vol. 62, no 3, p. 577-590Article in journal (Refereed) Published
Abstract [en]

Accurate and efficient in silico ranking of protein–protein binding affinities is useful for protein design with applications in biological therapeutics. One popular approach to rank binding affinities is to apply the molecular mechanics Poisson–Boltzmann/generalized Born surface area (MMPB/GBSA) method to molecular dynamics (MD) trajectories. Here, we identify protocols that enable the reliable evaluation of T-cell receptor (TCR) variants binding to their target, peptide-human leukocyte antigens (pHLAs). We suggest different protocols for variant sets with a few (≤4) or many mutations, with entropy corrections important for the latter. We demonstrate how potential outliers could be identified in advance and that just 5–10 replicas of short (4 ns) MD simulations may be sufficient for the reproducible and accurate ranking of TCR variants. The protocols developed here can be applied toward in silico screening during the optimization of therapeutic TCRs, potentially reducing both the cost and time taken for biologic development.

Place, publisher, year, edition, pages
American Chemical Society (ACS), 2022. Vol. 62, no 3, p. 577-590
National Category
Biochemistry Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-470562DOI: 10.1021/acs.jcim.1c00765ISI: 000746437900001PubMedID: 35049312OAI: oai:DiVA.org:uu-470562DiVA, id: diva2:1647752
Available from: 2022-03-28 Created: 2022-03-28 Last updated: 2025-02-20Bibliographically approved

Open Access in DiVA

fulltext(6170 kB)176 downloads
File information
File name FULLTEXT02.pdfFile size 6170 kBChecksum SHA-512
8e98120e7a581d0d492b73d267df2c130b32bec6ffff1220b97ac7e4aadeb23a226f615c5f334a6306fe59be1e45d02320c077caefa4311f048c73f0de71b3d0
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Authority records

Crean, Rory M.

Search in DiVA

By author/editor
Crean, Rory M.van der Kamp, Marc W.
In the same journal
Journal of Chemical Information and Modeling
BiochemistryMolecular Biology

Search outside of DiVA

GoogleGoogle Scholar
Total: 178 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 113 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf